You can remain anonymous if you wish or provide contact details if you are willing to share your story to raise awareness and help us in our mission
Absolute contraindications include: Active malignancy of any kind (GH and IGF-1 are growth-promoting signals) Active diabetic retinopathy (IGF-1 may worsen retinal vascularity) Pregnancy or breastfeeding Known hypersensitivity to any component of the formulation Pituitary tumours or untreated hypothalamic disease Relative contraindications requiring careful evaluation include pre-existing insulin resistance, type 2 diabetes, uncontrolled cardiovascular disease, and sleep apnoea (GH elevation can worsen upper airway tone in susceptible individuals)
Selective GH Stimulation: Unlike other GH-releasing peptides (e.g., GHRP-2, GHRP-6), Ipamorelin selectively induces GH release without significantly elevating cortisol or ACTH levels, even at doses up to 0.03 mg/kg, offering a cleaner endocrine profile
At lower doses, GLP-1 helps regulate cravings, reduces late-night snacking cycles, and supports a mild caloric deficit without tanking energy levels
placebo (0.97 vs 1.56 ml/min/1.73 m 2 per year, p 100 mg/g and consistently reduced UACR progression in patients with various degrees of albuminuria [23]